|
Christina A. Waters, Ph.D., President and COO:Dr. Christina Waters brings nearly twenty years of research and management experience to aTyr, in both early stage and large pharmaceutical companies. Prior to joining aTyr, she was the Director of Scientific Discovery at the Genomics Institute of the Novartis Research Foundation, where she designed and managed research and preclinical drug discovery development. She provided central guidance across the organization and has extensive experience with global project management and strategic positioning, drug discovery, technology discovery, pre-clinical development, and general operations. During her tenure, the department successfully produced preclinical drug candidates for Novartis, two of which entered clinical trials in 2006. Dr. Waters was previously the Preclinical Studies Program Manager and Studies Supervisor for cardiovascular and oncology indications at Miravant Medical Technologies, a pharmaceutical development company specializing in PhotoPoint(R) photodynamic therapy (PDT). She received her Ph.D. in Genetics from the University of California, Davis, and completed her degree at Syntex as a NIH Biotechnology Fellow. She was a Postdoctoral Scholar and Associate at the Howard Hughes Medical Institute in the Division of Biology, California Institute of Technology. Dr. Waters also completed an NIH Postdoctoral fellowship at University of California, Berkeley, and received a Bachelor of Science in Biology from San Diego State University. | 